Loading…

A Randomized Controlled Trial of Standard versus Customized Graduated Elastic Compression Stockings in Patients with Chronic Venous Disease

This study aimed to compare the efficacy of customized graduated elastic compression stockings (c-GECSs) based on lower leg parameter models with standard graduated elastic compression stockings (s-GECSs) in patients with chronic venous disease (CVD).OBJECTIVEThis study aimed to compare the efficacy...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery. Venous and lymphatic disorders (New York, NY) NY), 2023-09
Main Authors: Yang, Wen-Tao, Xiong, Ying, Wang, Sheng-Xing, Ren, Hua-Liang, Gong, Chi, Jin, Zhen-Yi, Wen, Jia-Hao, Zhang, Wang-De, Tao, Xiao-Ming, Li, Chun-Min
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to compare the efficacy of customized graduated elastic compression stockings (c-GECSs) based on lower leg parameter models with standard graduated elastic compression stockings (s-GECSs) in patients with chronic venous disease (CVD).OBJECTIVEThis study aimed to compare the efficacy of customized graduated elastic compression stockings (c-GECSs) based on lower leg parameter models with standard graduated elastic compression stockings (s-GECSs) in patients with chronic venous disease (CVD).In this randomized, single-blind, controlled trial, 79 patients with stage C2 or C3 CVD were assigned to one of two groups: c-GECSs or s-GECSs. The primary outcome was change to Venous Insufficiency Epidemiological and Economic Study-Quality of Life (VEINES-QOL) scores at months 1, 3, and 6 as compared to baseline. Secondary outcomes included compliance with wearing ECSs, interface pressure (IP) at the smallest circumference of the ankle (point B) and the largest circumference of the calf (point C), and calf volume (CV).METHODSIn this randomized, single-blind, controlled trial, 79 patients with stage C2 or C3 CVD were assigned to one of two groups: c-GECSs or s-GECSs. The primary outcome was change to Venous Insufficiency Epidemiological and Economic Study-Quality of Life (VEINES-QOL) scores at months 1, 3, and 6 as compared to baseline. Secondary outcomes included compliance with wearing ECSs, interface pressure (IP) at the smallest circumference of the ankle (point B) and the largest circumference of the calf (point C), and calf volume (CV).13 pairs of s-GECS and 2 pairs of c-GECS showed pressure values higher than the standard at either point B or C. The c-GECSs were significantly superior to s-GECSs in terms of score improvement at all three time points (month 1, 8.47 [7.47-9.45] vs. 5.89 [5.00-6.78]; month 3, 9.60 [8.47-10.72] vs. 6.72 [5.62-7.83]; month 6, 7.09 [5.93-8.24] vs. 3.92 [2.67-5.18], p < 0.0001). Besides, at month 1, the mean daily usage time of the c-GECS and s-GECS groups was 10.7 and 9.5 h, respectively (p < 0.05). Correlation analysis indicated a negative relationship between local high pressure and daily duration in the s-GECS group (rpb = -0.388, n = 38, p < .05). Variances in pressure were greater in the s-GECSs group. The c-GECSs showed advantage in maintaining pressure. Both c-GECSs and s-GECSs effectively reduced CV (mL), with no significant differences between groups (month 1, 90.0 [71.4-108.5] vs. 85.0 [65.6-104.2]; month 3, 9
ISSN:2213-3348
2213-3348
DOI:10.1016/j.jvsv.2023.08.017